Chronic effects of monoamine oxidase-B inhibitors on the behaviour of aged mice
- 31 December 1993
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 53 (9), 739-747
- https://doi.org/10.1016/0024-3205(93)90251-w
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Deprenyl reduces the death of motoneurons caused by axotomyJournal of Neuroscience Research, 1992
- Rescue of dying neurons: A new action for deprenyl in MPTP parkinsonismJournal of Neuroscience Research, 1991
- Effect of Deprenyl on the Progression of Disability in Early Parkinson's DiseaseNew England Journal of Medicine, 1989
- Deprenyl suppresses the oxidant stress associated with increased dopamine turnoverAnnals of Neurology, 1989
- The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's DiseaseScience, 1989
- L-Deprenyl in Alzheimer's DiseaseArchives of General Psychiatry, 1987
- Increased life expectancy resulting from addition of l-deprenyl to Madopar® treatment in Parkinson's disease: A longterm studyJournal of Neural Transmission, 1985
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidaseBiochemical and Biophysical Research Communications, 1984
- EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINEBritish Journal of Pharmacology, 1977
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal of Neural Transmission, 1975